Subscribe to RSS
DOI: 10.1055/s-0030-1259947
Synthesis of Trifluoromethylated and gem-Difluoromethylenated Biologically Interesting Compounds from Fluorine-Containing Synthons
Publication History
Publication Date:
07 April 2011 (online)
![](https://www.thieme-connect.de/media/synlett/201108/lookinside/thumbnails/10.1055-s-0030-1259947-1.jpg)
Abstract
A number of fluorinated versatile building blocks (synthons) were developed for the synthesis of trifluoromethylated and gem-difluoromethylenated biologically interesting compounds. Extensive studies have demonstrated that fluorine atoms have profound stereoelectronic effects on neighboring groups, leading to special performance of the fluorine-containing compounds in reactions. It was found that, in comparison with their nonfluorinated counterparts, a C-O bond adjacent to a CF2 group was more stabilized which made it hard to be substituted in a SN2 way; double bond next to fluorinated groups was too electron deficient to participate in ring-closing-metathesis (RCM) reactions, and the carbocation that was strongly destabilized by neighboring CF2 group reacted immediately with nucleophilic molecules to produce unexpected product and so on. Thus improved methodologies were developed to achieve the desired transformations. The conformational analysis of difluorothiouridine suggested that the gem-difluoro atoms governed the overall conformation of the sugar ring and nucleobase. The biological evaluation of the synthetic difluoromethylenated azasugars towards eight glycosidases showed that the CF2 group decreased the pK a of azasugars which enhanced their binding affinity and selectivity to glycosidases.
1 Introduction
2 Synthesis of Trifluoromethylated Building Blocks and their Application for the Preparation of Biologically Interesting Molecules
2.1 Improved FSO2CF2CO2Me/CuI Method for the Synthesis of Trifluoromethylated Retinoid
2.2 Preparation of α-Trifluoromethyl-α,β-Unsaturated Esters for the Synthesis of Trifluoromethylated Nucleosides and Prolines
2.3 Development of Trifluoropropenyl-Containing Synthons for the Preparation of Trifluoromethylated Analogues of Amino Acids, Sugars, and Macrolactones
3 Preparation of Difluoromethylenated Building Blocks and their Application for the Synthesis of Difluoromethylenated Nucleosides, α,β-Uunsaturated-β-lactones and Azasugars
3.1 Novel Route to Difluorohomoallyl Alcohol and its Wide Utility in the Synthesis of Difluoromethylenated Nucleosides
3.2 Construction of Difluoromethylenated Synthons via Silicon-Induced Reformatskii-Claisen Rearrangement and their Application for the Preparation of Difluoromethylenated Nucleosides
3.3 Synthesis of Azanucleosides Bearing Exocyclic CF2H Group Using a Wittig-Type Olefination Approach
3.4 Conformational Analysis of d-2′-Deoxy-2′,2′-difluoro-4′-dihydro-4′-thiouridine
3.5 Synthesis of Difluoromethylenated Six-Membered α,β-Unsaturated-β-lactones and other Related Compounds
3.6 Synthesis and Biological Evaluation of Difluoromethylenated Azasugars
4 Conclusion
Key words
fluorinated molecules - building blocks - biologically interesting compounds
-
1a
Pauling L. The Nature of the Chemical Bond Cornell University Press; Ithaca: 1960. -
1b
Bondi A. J. Phys. Chem. 1964, 68: 441 - 2
O’Hagan D. Chem. Soc. Rev. 2008, 37: 308 -
3a
Clader JW. J. Med. Chem. 2003, 47: 1 -
3b
Smith DH.van de Waterbeemd H.Walker DK. Pharmacokinetics and Metabolism in Drug Design, Methods and Principles in Medicinal Chemistry Vol. 13: Wiley-VCH; Weinheim: 2001. -
3c
Tsuchiya T. Adv. Carbohydr. Chem. Biochem. 1990, 48: 91 -
4a
Böhm H.-J.Banner D.Bendels S.Kansy M.Kuhn B.Müller K.Obst-Sander U.Stahl M. ChemBioChem 2004, 5: 637 -
4b
Müller K.Faeh C.Diederich F. Science 2007, 317: 1881 -
5a
Guschlbauer W.Jankowski K. Nucleic Acids Res. 1980, 8: 1421 -
5b
Cheng DM.Kan L.-S.Ts’o POP.Uesugi S.Takatsuka Y.Ikehara M. Biopolymers 1983, 22: 1427 -
5c
Uesugi S.Kaneyasu T.Imura J.Ikehara M.Cheng DM.Kan L.Ts’o POP. Biopolymers 1983, 22: 1189 -
5d
Van der Boogaart JE.Kalinichenko EN.Podkopaeva TL.Mikhailopulo IA.Altona C. Eur. J. Biochem. 1994, 221: 759 -
5e
Barchi JJ.Karki RG.Nicklaus MC.Siddiqui MA.George C.Mikhailopulo IA.Marquez VE. J. Am. Chem. Soc. 2008, 130: 9048 -
5f
Leroux F.Jeschke P.Schlosser M. Chem. Rev. 2005, 105: 827 -
6a
Swain C.Rupniak NMJ. Annu. Rep. Med. Chem. 1999, 34: 51 -
6b
Wermuth CG. Rational Approaches in Drug Design Prous Science; Barcelona: 2001. p.3-20 - 7
Park BK.Kitteringham NR.O’Neill PM. Annu. Rev. Pharmacol. Toxicol. 2001, 41: 443 - 8
Mikami K.Itoh Y.Yamanaka M. Chem. Rev. 2004, 104: 1 -
9a
Ojima I.McCarthy JR.Welch JT. Biomedical Frontiers of Fluorine Chemistry ACS; Washington: 1996. -
9b
Bégué J.-P.Bonnet-Delpon D. Chimie Bioorganique et Médicinale du Fluor EDP Sciences, CNRS Publishers; Paris: 2005. -
9c
Smart BE. In Organofluorine Chemistry, Principles and Commercial ApplicationsBanks RE.Smart BE.Tatlow JC. Plenum Press; New York: 1994. p.Chap. 3 -
9d
Hiyama T. Organofluorine Compounds, Chemistry and Applications Springer; Berlin: 2000. -
9e
Shimizu M.Hiyama T. Angew. Chem. Int. Ed. 2005, 44: 214 -
9f
Hagmann WK. J. Med. Chem. 2008, 51: 4359 -
9g
Purser S.Moore PR.Swallow S.Gouverneur V. Chem. Soc. Rev. 2008, 37: 320 - 10
Langlois BR.Billard T. Synthesis 2003, 185 - 11
Chen Q.-Y.Wu S.-W. J. Chem. Soc., Chem. Commun. 1989, 705 - 12
Qing F.-L.Fan J.Sun H.-B.Yue X.-J. J. Chem. Soc., Perkin Trans. 1 1997, 3053 - 13
Boehm MF.Zhang L.Badea BA.White SK.Mais DE.Berger E.Suto CM.Goldman ME.Heyman RA. J. Med. Chem. 1994, 37: 2930 - 14
Qing F.-L.Fan J. Bioorg. Med. Chem. Lett. 1997, 7: 2117 - 15
Zhang X.Qing F.-L.Yang Y.Yu J.Fu X.-K. Tetrahedron Lett. 2000, 41: 2953 - 16
Qing F.-L.Zhang X. Tetrahedron Lett. 2001, 42: 5929 - 17
De Clercq E. J. Clin. Virol. 2004, 30: 115 -
18a
Agrawal S.Zhao Q. Curr. Opin. Chem. Biol. 1998, 2: 519 -
18b
Li F.Maag H.Alfredson T. J. Pharm. Sci. 2008, 97: 1109 -
19a
Ternansky RJ.Hertel LW. Organofluorine Compounds in Medicinal Chemistry and Biomedical ApplicationsFiller R.Kobayashi Y.Yagupolski LM. Elsevier; Amsterdam: 1993. p.23 -
19b
Pankiewicz KW. Carbohydr. Res. 2000, 327: 87 -
19c
Meng W.-D.Qing F.-L. Curr. Top. Med. Chem. 2006, 6: 1499 -
19d
Liu P.Sharon A.Chu CK. J. Fluorine Chem. 2008, 129: 743 -
19e
Qiu X.-L.Xu X.-H.Qing F.-L. Tetrahedron 2010, 66: 789 - 20
Johnson C.Bhumralkar DP.De Clercq E. Nucleosides Nucleotides 1995, 14: 185 - 21
Zhang X.Qing F.-L.Yu Y. J. Org. Chem. 2000, 65: 7075 - 22
Zhang X.Qing F.-L. J. Org. Chem. 2002, 67: 1016 - 23
Qiu X.-l.Qing F.-l. J. Chem. Soc., Perkin Trans. 1 2002, 2052 - 24
Jiang Z.-X.Qin Y.-Y.Qing F.-L. J. Org. Chem. 2003, 68: 7544 -
25a
Bevilacqua PF.Keith DD.Roberts JL. J. Org. Chem. 1984, 49: 1430 -
25b
Loh T.-P.Li X.-R. Angew. Chem., Int. Ed. Engl. 1997, 36: 980 -
25c
Loh T.-P.Li X.-R. Eur. J. Org. Chem. 1999, 1893 -
25d
McBee ET.Pierce OR.Smith DD. J. Am. Chem. Soc. 1954, 76: 3722 - 26
Kollonitsch J.Patchett AA.Marburg S.Maycock AL.Perkins LM.Doldouras GA.Duggan DE.Aster SD. Nature (London) 1978, 275: 906 - 27
Tsushima T.Kawada K.Ishihara S.Uchida N.Shiratori O.Higaki J.Hirata M. Tetrahedron 1988, 44: 5375 - 28
Dubois J.Dugave C.Foures C.Kaminsky M.Tabet JC.Bory S.Gaudry M.Marquet A. Biochemistry 1991, 30: 10506 - 29
Yoder NC.Kumar K. Chem. Soc. Rev. 2002, 31: 335 -
30a
Bilgiçer B.Fichera A.Kumar K. J. Am. Chem. Soc. 2001, 123: 4393 -
30b
Wang P.Tang Y.Tirrell DA. J. Am. Chem. Soc. 2003, 125: 6900 -
30c
Qiu X.-L.Meng W.-D.Qing F.-L. Tetrahedron 2004, 60: 6711 - 31
Jiang Z.-X.Qing F.-L. J. Org. Chem. 2004, 69: 5486 - 32
Wang B.-L.Jiang Z.-X.You Z.-W.Qing F.-L. Tetrahedron 2007, 63: 12671 -
33a
Takahashi T.Kusaka S.-i.Doi T.Sunazuka T.Omura S. Angew. Chem. Int. Ed. 2003, 42: 5230 -
33b
Ishihara K.Kawaguchi T.Matsuya Y.Sakurai H.Saiki I.Nemoto H. Eur. J. Org. Chem. 2004, 3973 -
33c
Matsuya Y.Kawaguchi T.Ishihara K.Ahmed K.Zhao QL.Kondo T.Nemoto H. Org. Lett. 2006, 8: 4609 - 34
Wang B.-L.Yu F.Qiu X.-L.Jiang Z.-X.Qing F.-L. J. Fluorine Chem. 2006, 127: 580 - 35
Chen Q.Qiu X.-L.Qing F.-L. J. Org. Chem. 2006, 71: 3762 - 36
Lu W.Chan TH. J. Org. Chem. 2000, 65: 8589 - 37
Bernardi L.Cerè V.Femoni C.Pollicino S.Ricci A. J. Org. Chem. 2003, 68: 3348 - 38
Chen Q.Qiu X.-L.Qing F.-L. J. Fluorine Chem. 2007, 128: 1182 - 39
Blackburn GM.England DA.Kolkmann F. J. Chem. Soc., Chem. Commun. 1981, 930 -
40a
Hertel LW.Boder GB.Kroin JS.Rinzel SM.Poore GA.Todd GC.Grindey GB. Cancer Res. 1990, 50: 4417 -
40b
Noble S.Goa KL. Drugs 1997, 54: 447 -
41a
Zhang X.Xia H.Dong X.Jin J.Meng W.-D.Qing F.-L. J. Org. Chem. 2003, 68: 9026 -
41b
Xu X.-H.Qiu X.-L.Zhang X.Qing F.-L. J. Org. Chem. 2006, 71: 2820 - 42
Mathé C.Gosselin G. Antiviral Res. 2006, 71: 276 - 43
Bio MM.Xu F.Waters M.Williams JM.Savary KA.Cowden CJ.Yang C.Buck E.Song ZJ.Tschaen DM.Volante RP.Reamer RA.Grabowski EJJ.
J. Org. Chem. 2004, 69: 6257 - 44
Yokoyama M. Synthesis 2000, 1637 - 45
Zheng F.Zhang X.-H.Qiu X.-L.Zhang X.Qing F.-L. Org. Lett. 2006, 8: 6083 -
46a
Chang CN.Doong SL.Zhou JH.Beach JW.Jeong LS.Chu CK.Tsai CH.Cheng YC.Liotta D.Schinazi R. J. Biol. Chem. 1992, 267: 13938 -
46b
Doong SL.Tsai CH.Schinazi RF.Liotta DC.Cheng YC. Proc. Natl. Acad. Sci. U.S.A. 1991, 88: 8495 - 47
Grove KL.Guo X.Liu S.-H.Gao Z.Chu CK.Cheng Y.-C. Cancer Res. 1995, 55: 3008 - 48
Wu Y.-Y.Zhang X.Meng W.-D.Qing F.-L. Org. Lett. 2004, 6: 3941 - 49
Shaw G.Warrener RN. J. Chem. Soc. 1958, 157 - 50
Yue X.Qiu X.-L.Qing F.-L. J. Fluorine Chem. 2008, 129: 866 - 51
Xu X.-H.Trunkfield AE.Bugg TDH.Qing F.-L. Org. Biomol. Chem. 2008, 6: 157 -
52a
Dini C.Collette P.Drochon N.Guillot JC.Lemoine G.Mauvais P.Aszodi J. Bioorg. Med. Chem. Lett. 2000, 10: 1839 -
52b
Takatsuki A.Kawamura K.Okina M.Kodama Y.Ito T.Tamura G. Agric. Biol. Chem. 1977, 41: 2307 - 53
Kusaka T.Yamamoto H.Shibata M.Muroi M.Kishi T.Mizuno K. J. Antibiot. 1968, 21: 255 - 54
Yaginuma S.Muto N.Tsujino M.Sudate Y.Hayashi M.Otani M. J. Antibiot. 1981, 34: 359 -
55a
Crimmins MT. Tetrahedron 1998, 54: 9229 -
55b
Rodrguez JB.Comin MJ. Mini-Rev. Med. Chem. 2003, 3: 95 -
55c
Ferrero M.Gotor V. Chem. Rev. 2000, 100: 4319 - 56
Weller S.Radomski KM.Lou Y.Stein DS. Antimicrob. Agents Chemother. 2000, 44: 2052 - 57
Yang Y.-Y.Meng W.-D.Qing F.-L. Org. Lett. 2004, 6: 4257 - 58
Greuter H.Lang RW.Romann AJ. Tetrahedron Lett. 1988, 29: 3291 - 59
Martín Castro AM. Chem. Rev. 2004, 104: 2939 - 60
Yang Y.-Y.Xu J.You Z.-W.Xu X.-h.Qiu X.-L.Qing F.-L. Org. Lett. 2007, 9: 5437 - 61
Xu J.Qiu X.-L.Qing F.-L. Beilstein J. Org. Chem. 2008, 4: No.18 - 62
Zheng F.Zhang X.Qing F.-L. Chem. Commun. 2009, 1505 -
63a
Qiu X.-L.Qing F.-L. Synthesis 2004, 334 -
63b
Qiu X.-L.Qing F.-L. J. Org. Chem. 2005, 70: 3826 - 64
Zheng F.Fu L.Wang R.Qing F.-L. Org. Biomol. Chem. 2010, 8: 163 - 65
Davies-Coleman MT.Rivett DEA. Prog. Chem. Org. Nat. Prod. 1989, 55: 1 -
66a
de Fátima .Kohn LK.de Carvalho JE.Pilli RA. Biorg. Med. Chem. 2006, 14: 622 -
66b
Buck SB.Hardouin C.Ichikawa S.Soenen DR.Gauss CM.Hwang I.Swingle MR.Bonness KM.Honkanen RE.Boger DL. J. Am. Chem. Soc. 2003, 125: 15694 -
66c
Kumar P.Naidu SV. J. Org. Chem. 2006, 71: 3935 - 67
You Z.-W.Wu Y.-Y.Qing F.-L. Tetrahedron Lett. 2004, 45: 9479 - 68
You Z.-W.Zhang X.Qing F.-L. Synthesis 2006, 2535 - 69
You Z.-W.Jiang Z.-X.Wang B.-L.Qing F.-L. J. Org. Chem. 2006, 71: 7261 - 70
Lin J.Qiu X.-L.Qing F.-L. Beilstein J. Org. Chem. 2010, 6: No. 37 - 71
Xu J.Zhang X.Qiu X.-L.Qing F.-L. Synthesis 2009, 602 -
72a
Butters TD.Dwek RA.Platt FM. Chem. Rev. 2000, 100: 4683 -
72b
Sears P.Wong C.-H. Angew. Chem. Int. Ed. 1999, 38: 2300 -
73a
Fleet GWJ.Shaw AN.Evans SV.Fellows LE. J. Chem. Soc., Chem. Commun. 1985, 841 -
73b
Compain P.Martin OR. Curr. Top. Med. Chem. 2003, 3: 541 -
74a
Butters TD.Dwek RA.Platt FM. Curr. Top. Med. Chem. 2003, 3: 561 -
74b
Butters TD.van den Broek LAGM.Fleet GWJ.Krulle TM.Wormald MR.Dwek RA.Platt FM. Tetrahedron: Asymmetry 2000, 11: 113 - 75
Wang R.-W.Qing F.-L. Org. Lett. 2005, 7: 2189 - 76
Wang R.-W.Qiu X.-L.Bols M.Ortega-Caballero F.Qing F.-L. J. Med. Chem. 2006, 49: 2989 - 77
Li R.-j.Bols M.Rousseau C.Zhang X.-g.Wang R.-w.Qing F.-L. Tetrahedron 2009, 65: 3717